Merck (MRK) PT Raised to $95 at Cowen on Gefapixant Data
Tweet Send to a Friend
Cowen analyst Steve Scala raised the price target on Merck (NYSE: MRK) to $95.00 (from $88.00) after the presented full ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
